FDA Inspection
Solvias USA, LLCSolvias USA, LLC – FDA Inspection, Jul 16, 2026
Record Details
This FDA Inspection record concerns Solvias USA, LLC, with an inspection on July 16, 2026, issued by the New England District Office, covering human drugs.
View Company Profile
ID · a6ccda40-4da4-4f94-9689-1b1c7b6dc892
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1326666
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.68(b)input/output verification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Solvias USA, LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 1, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 19, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Solvias USA, LLC
- FDA Inspection 1192801 - 2022-12-01
- FDA Inspection 1037090 - 2017-12-13
- FDA Inspection 927573 - 2015-05-15
- FDA Inspection 763442 - 2012-01-19
- FDA Inspection 654871 - 2010-03-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.